Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
21:51:27 EDT Wed 01 May 2024
Enter Symbol
or Name
USA
CA



C:BETR - BetterLife Pharma Inc. - http://www.abetterlifepharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
BETR - C  20.00.11·0.1159.50.115184.221190.115  0.12  0.1050.12  0.0512:14:0113:4815 min RT 2¢
CSE - C20.00.11·0.1159.50.115181.321120.115  0.12  0.1050.12  0.0512:14:0115 min
Omega - O 0.105-0.01-8.70.510.105  0.105  0.10510:03:3215 min
CX2 - H 0.1151.5020.105  0.115  0.10511:59:2515 min
CXD - D 0.1150.83    Mar 2015 min
TriAct - M 0.1150.061    Jul 30-2015 min

Recent Trades - Last 10 of 19
Time ETExPriceChangeVolumeBuyerSellerMarkers
12:14:01C0.115 7,00080 National Bank7 TD SecK
12:14:01C0.115 8,00079 CIBC7 TD SecK
12:07:37C0.120.00540,0007 TD Sec7 TD SecK
12:07:37C0.120.00510,0007 TD Sec7 TD SecK
11:59:25H0.115 1,00080 National Bank1 AnonymousK
11:59:25C0.115 12,00080 National Bank79 CIBCK
11:59:25C0.115 60,00080 National Bank80 National BankK
11:45:31C0.11-0.00528836 Latimer84 ITG84E
11:45:31C0.11-0.00542,0007 TD Sec84 ITG84K
11:25:18M0.105-0.01637 TD Sec7 TD SecE

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-05-01 13:48C:BETR0.115News ReleaseBetterlife begins IND-enabling studies for BETR-001
2024-04-03 12:12C:BETR0.095News ReleaseBetterlife raises $1.16-million with debentures
2024-03-04 12:56C:BETR0.09News ReleaseBetterlife talks Carelton University article
2024-01-02 10:18C:BETR0.06News ReleaseBetterlife closes $300,000 debenture offering
2023-12-29 10:33C:BETR0.07SEDAR Interim MD & ASEDAR Interim MD & A
2023-12-29 10:22C:BETR0.07SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-12-18 11:29C:BETR0.06News ReleaseBetterlife Pharma closes $200,000 private placement
2023-11-30 13:11C:BETR0.055News ReleaseBetterlife Pharma extends 6.38 million warrants to 2025
2023-11-15 10:43C:BETR0.06News ReleaseBetterlife Pharma patent application published by USPTO
2023-09-27 18:50C:BETR0.07SEDAR Interim MD & ASEDAR Interim MD & A
2023-09-27 18:48C:BETR0.07SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-09-14 14:10C:BETR0.075News ReleaseBetterlife Pharma to hold investor update call Sept. 18
2023-09-12 11:37C:BETR0.09News ReleaseBetterlife Pharma talks BETR-001 animal safety data
2023-09-05 14:58C:BETR0.085News ReleaseBetterlife points to recent article discussing BETR-001
2023-07-13 12:59C:BETR0.075News ReleaseBetterlife Pharma talks ACP guidelines for MDD treatment
2023-06-28 13:14C:BETR0.075SEDAR MD & ASEDAR MD & A
2023-06-28 13:13C:BETR0.075SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-06-27 13:04C:BETR0.08News ReleaseBetterlife Pharma fast-tracks BETR-001 U.S. patent
2023-06-08 12:18C:BETR0.085News ReleaseBetterlife midway through BETR-001 toxicology study
2023-05-31 17:37C:BETR0.09SEDAR Annual Information FormSEDAR Annual Information Form